Matt Handel, President, Skyran Biologics, Inc.
Matt Handel is a life sciences entrepreneur, executive and board director who has led Skyran Biologics, Inc. since August 2017. Most recently he founded and headed Recensa. Matt has worked closely with colleagues in industry, venture capital, banking and government, both in the U.S. and globally.
Matt began his career at Merck & Co. and then spent 11 years at Shire Pharmaceuticals in business development, business intelligence and product leadership. Matt was most recently at G&W Laboratories, Inc., where he built a new product selection process and identified business opportunities. Matt is a Board Director of PolyAurum, LLC, an oncology company.
Matt earned his M.S. from the MIT Sloan School of Management and his B.A. from Princeton University. He sits on several non-profit Boards that support human services in the Philadelphia area. In his younger days, Matt was a three-day champion on the television show Jeopardy.